Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fortress Biotech

3.60
-0.1100-2.96%
Post-market: 3.600.00000.00%19:59 EDT
Volume:2.43M
Turnover:8.83M
Market Cap:107.12M
PE:-1.64
High:3.90
Open:3.81
Low:3.49
Close:3.71
52wk High:3.90
52wk Low:1.33
Shares:29.75M
Float Shares:21.69M
Volume Ratio:0.97
T/O Rate:11.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1959
EPS(LYR):-2.6890
ROE:-784.32%
ROA:-40.94%
PB:2.44
PE(LYR):-1.34

Loading ...

Oct 02, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Sep 27, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Sep 25, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Sep 23, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 14, 2024

Major Issues Report

Form 8-K - Current report
Jul 25, 2024

Major Issues Report

Form 8-K - Current report
Jul 19, 2024

Major Issues Report

Form 8-K - Current report
Jul 05, 2024

Major Issues Report

Form 8-K - Current report
Jun 28, 2024

Major Issues Report

Form 8-K - Current report
Jun 28, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 25, 2024

Correspondence

Form CORRESP - Correspondence
Jun 25, 2024

Major Issues Report

Form 8-K - Current report
May 31, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 31, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 29, 2024

Correspondence

Form CORRESP - Correspondence
May 29, 2024

Major Issues Report

Form 8-K - Current report
May 17, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2024

Major Issues Report

Form 8-K - Current report